Supply Issues Smiths Medical Vascular Access Needles FTR1309 and FTR406 (ICN 2679)
Important Customer Notice Resolved
Ref: 2024/2679
ICN Number: 2679
- The supply issue with Vascular Access Needles from Smiths Medical is now resolved.
- FTR1309 and FTR406 are now available to order through our online catalogue.
- This ICN is now closed.
Change:
- Smiths Medical has informed us of a supply issue with its Vascular Access Needles.
- The two product codes affected are:
- FTR1309 – Safety Needle Vascular Access 19G x 19mm (0.75 inch) Huber Type Gripper Plus Non Coring without Y Site
- FTR406 – Needle Vascular Access 22G x 19mm (0.75 inch) Gripper with Y Site and 8 inch Extension Latex Free Injection Port.
- The supply issue is due to supplier manufacturing issues.
Impact:
- FTR1309 is currently suspended and unavailable to order.
- FTR406 is currently available whilst our stocks last and will then become unavailable.
- Potential indirect alternative products are available to order through our online catalogue.
- See our Downloads ▼ section to access the product listing for further information on the affected product codes and potential alternatives.
- The supply issue is anticipated to be resolved by 30 November 2024.
Next Steps:
- Customers are advised to log into our website to view the potential indirect alternative products.
- The continuing supply issue is being monitored in conjunction with the supplier and we will continue to review the stock situation to minimise further disruption and update this ICN with the latest information as it becomes available.
- However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
- If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.
Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.